Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas

References

• Zhou M, Cen L, Chen T, et al. The prognostic significance of the serum p53 protein concentration in Chinese patients with non-Hodgkin lymphoma. Turk J Haematol 2012;29:376–384.
   PubMed Web of Science ®Google Scholar
• Hang Q, Fei M, Hou S, et al. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 Kip1 on Thr187 and cell proliferation. Med Oncol 2012;29:3504–3514.
   PubMed Web of Science ®Google Scholar
• Chao MP. Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma - novel and emerging therapies. Cancer Manag Res 2013;5:251–269.
   PubMedGoogle Scholar
• Edwards SK, Moore CR, Liu Y, et al. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. BMC Cancer 2013;13:481.
   PubMed Web of Science ®Google Scholar
• Lwin T, Hazlehurst LA, Li Z, et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin’s lymphoma cells. Leukemia 2007;21:1521–1531.
   PubMed Web of Science ®Google Scholar
• Lwin T, Hazlehurst LA, Dessureault S, et al. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Blood 2007;110:1631–1638.
   PubMed Web of Science ®Google Scholar
• Lwin T, Lin J, Choi YS, et al. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 2010;116:5228–5236.
   PubMed Web of Science ®Google Scholar
• Lwin T, Crespo LA, Wu A, et al. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis. Leukemia 2009;23:170–177.
   PubMed Web of Science ®Google Scholar
• Burger JA, Ghia P, Rosenwald A, et al. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009;114:3367–3375.
   PubMed Web of Science ®Google Scholar
• Shao S, Huang X, Wang Y, et al. A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma. Int J Hematol 2014;99:57–68.
   PubMed Web of Science ®Google Scholar
• Huang X, Wang Y, Nan X, et al. The role of the orphan G protein-coupled receptor 37 (GPR37) in multiple myeloma cells. Leuk Res 2014;38:225–235.
   PubMed Web of Science ®Google Scholar
• Westhoff MA, Zhou S, Bachem MG, et al. Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells. Oncogene 2008;27:5169–5181.
   PubMed Web of Science ®Google Scholar
• Fernandez-Vidal A, Ysebaert L, Didier C, et al. Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia. Cancer Res 2006;66:7128–7135.
   PubMed Web of Science ®Google Scholar
• Lwin T, Zhao X, Cheng F, et al. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J Clin Invest 2013;123:4612–4626.
   PubMed Web of Science ®Google Scholar
• Fei M, Hang Q, Hou S, et al. Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells. Int J Hematol 2013;98:446–455.
   PubMed Web of Science ®Google Scholar
• Fei M, Hang Q, Hou S, et al. Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells. Mol Cell Biochem 2014;386:177–187.
   PubMed Web of Science ®Google Scholar
• Yagci M, Yegin ZA, Akyurek N, et al. TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic lymphocytic leukemia. Leuk Res 2013;37:665–670.
   PubMed Web of Science ®Google Scholar
• Flamme I, Krieg M, Plate KH. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha. Am J Pathol 1998;153:25–29.
   PubMed Web of Science ®Google Scholar
• Langdon JM, Schroeder JT, Vonakis BM, et al. Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models. J Leukoc Biol 2008;84:1151–1158.
   PubMed Web of Science ®Google Scholar
• Raghupathi R, Strauss KI, Zhang C, et al. Temporal alterations in cellular Bax:Bcl-2 ratio following traumatic brain injury in the rat. J Neurotrauma 2003;20:421–435.
   PubMed Web of Science ®Google Scholar
• Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 2011; 351:41–58.
   PubMed Web of Science ®Google Scholar
• Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron 2000;25:11–14.
   PubMed Web of Science ®Google Scholar
• Li M, Yang X, Zhang J, et al. Effects of EHD2 interference on migration of esophageal squamous cell carcinoma. Med Oncol 2013;30:396.
   PubMed Web of Science ®Google Scholar
• Xue Q, Zhou Y, Wan C, et al. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Exp Mol Pathol 2013;95:313–318.
   PubMed Web of Science ®Google Scholar
• Amson R, Pece S, Marine JC, et al. TPT1/ TCTP-regulated pathways in phenotypic reprogramming. Trends Cell Biol 2013;23: 37–46.
   PubMed Web of Science ®Google Scholar
• Chen SH, Wu PS, Chou CH, et al. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell 2007;18:2525–2532.
   PubMed Web of Science ®Google Scholar
• Wu D, Guo Z, Min W, et al. Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein. Exp Ther Med 2012;3: 437–442.
   PubMed Web of Science ®Google Scholar
• Trevisan R, Daprai L, Paloschi L, et al. Antiapoptotic effect of human T-cell leukemia virus type 1 tax protein correlates with its creb transcriptional activity. Exp Cell Res 2006;312:1390–1400.
   PubMed Web of Science ®Google Scholar
• Wei G, Chen YB, Chen DF, et al. beta-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AbetaPP/PS1 mice. J Alzheimers Dis 2013;33:863–880.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao H, Zhang X, et al. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Res Bull 2013;96:45–53.
   PubMed Web of Science ®Google Scholar
• Yagi K, Yamamoto K, Umeda S, et al. Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells. Histopathology 2013;62:414–420.
   PubMed Web of Science ®Google Scholar
• Mraz M, Zent CS, Church AK, et al. Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance. Br J Haematol 2011;155:53–64.
   PubMed Web of Science ®Google Scholar
• Wang K, Jiang Y, Zheng W, et al. Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma. PLoS One 2013;8:e56829.
   PubMed Web of Science ®Google Scholar
• Bonavida B. Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions. Oncogene 2007;26:3629–3636.
   PubMed Web of Science ®Google Scholar
• Garrido SM, Appelbaum FR, Willman CL, et al. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol 2001;29:448–457.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Konoplev S, Hu W, et al. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002;16:1713–1724.
   PubMed Web of Science ®Google Scholar
• Nefedova Y, Cheng P, Alsina M, et al. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 2004;103:3503–3510.
   PubMed Web of Science ®Google Scholar
• Mudry RE, Fortney JE, York T, et al. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000;96: 1926–1932.
   PubMed Web of Science ®Google Scholar
• Nefedova Y, Landowski TH, Dalton WS. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 2003;17:1175–1182.
   PubMed Web of Science ®Google Scholar
• Wang X, Li C, Ju S, et al. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation. Leuk Lymphoma 2011;52:1991–1998.
   PubMed Web of Science ®Google Scholar
• Dong-Feng Z, Ting L, Cheng C, et al. Silencing HIF-1alpha reduces the adhesion and secretion functions of acute leukemia hBMSCs. Braz J Med Biol Res 2012;45:906–912.
   PubMed Web of Science ®Google Scholar
• Schrader A, Meyer K, von Bonin F, et al. Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas. Cell Commun Signal 2012;10:43.
   PubMed Web of Science ®Google Scholar
• Bodo J, Zhao X, Sharma A, et al. The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways. Br J Haematol 2013;163:72–80.
   PubMed Web of Science ®Google Scholar